Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis

Background. Notwithstanding the mounting evidence to suggest that systemic lupus erythematosus (SLE) accelerates the progression of atherosclerosis, the mechanisms underlying this phenomenon are yet to be completely understood. This research examined the molecular mechanism behind this vascular comp...

Full description

Bibliographic Details
Main Authors: Han Zhang, Yinde Huang, Xin Li, Wenbin Chen, Yu Lun, Jian Zhang
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2023/4508436
_version_ 1797647592358674432
author Han Zhang
Yinde Huang
Xin Li
Wenbin Chen
Yu Lun
Jian Zhang
author_facet Han Zhang
Yinde Huang
Xin Li
Wenbin Chen
Yu Lun
Jian Zhang
author_sort Han Zhang
collection DOAJ
description Background. Notwithstanding the mounting evidence to suggest that systemic lupus erythematosus (SLE) accelerates the progression of atherosclerosis, the mechanisms underlying this phenomenon are yet to be completely understood. This research examined the molecular mechanism behind this vascular complication. Methods. The Gene Expression Omnibus database was retrieved to acquire the gene expression datasets for SLE (GSE109248) and atherosclerosis (GSE100927). The shared differentially expressed genes (DEGs) of SLE and atherosclerosis were screened with the help of the “limma” package in R software, followed by function enrichment analysis, protein–protein interaction (PPI) network construction, key module analysis, hub gene selection, and coexpression analysis. Results. In GSE109248 and GSE100927, 1195 and 418 DEGs in totals were identified, respectively. Subsequently, we acquired 78 common DEGs (70 upregulated genes and eight downregulated genes) with the same expression trends by using the Venn diagram. Finally, 12 hub genes, including PTPRC, TYROBP, FCGR3A, ITGAX, LCP2, IL1B, IRF8, LILRB2, CD68, C1QB, CCR7, and C1QA were identified by using seven different algorithms in Cytohubba. The functional analysis illustrates that these genes were predominantly enriched in immune and inflammation response, lipid and atherosclerosis, and osteoporosis. These results indicate an important role of SLE in inducing excessive inflammation, which may be medicate by these hub genes and can induce osteoporosis and imbalance of the normal mineral balance in the body as well as lipid abnormalities, which eventually leads to premature onset of atherosclerosis. In total, nine transcription factors (TFs) that may participate in regulating the function of these genes were identified. All hub genes and four TFs were validated successfully. Conclusion. The results of our research show that SLE and atherosclerosis have common DEGs, pathophysiology, and hub genes. These findings can provide fresh evidence and insights into a further investigation into the mechanisms at play.
first_indexed 2024-03-11T15:19:44Z
format Article
id doaj.art-03807381e77e4f08980c0c9c962d1298
institution Directory Open Access Journal
issn 1466-1861
language English
last_indexed 2024-03-11T15:19:44Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Mediators of Inflammation
spelling doaj.art-03807381e77e4f08980c0c9c962d12982023-10-29T00:00:03ZengHindawi LimitedMediators of Inflammation1466-18612023-01-01202310.1155/2023/4508436Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset AtherosclerosisHan Zhang0Yinde Huang1Xin Li2Wenbin Chen3Yu Lun4Jian Zhang5Department of Vascular and Thyroid SurgeryDepartment of Vascular and Thyroid SurgeryDepartment of Vascular and Thyroid SurgeryDepartment of Vascular and Thyroid SurgeryDepartment of Vascular and Thyroid SurgeryDepartment of Vascular and Thyroid SurgeryBackground. Notwithstanding the mounting evidence to suggest that systemic lupus erythematosus (SLE) accelerates the progression of atherosclerosis, the mechanisms underlying this phenomenon are yet to be completely understood. This research examined the molecular mechanism behind this vascular complication. Methods. The Gene Expression Omnibus database was retrieved to acquire the gene expression datasets for SLE (GSE109248) and atherosclerosis (GSE100927). The shared differentially expressed genes (DEGs) of SLE and atherosclerosis were screened with the help of the “limma” package in R software, followed by function enrichment analysis, protein–protein interaction (PPI) network construction, key module analysis, hub gene selection, and coexpression analysis. Results. In GSE109248 and GSE100927, 1195 and 418 DEGs in totals were identified, respectively. Subsequently, we acquired 78 common DEGs (70 upregulated genes and eight downregulated genes) with the same expression trends by using the Venn diagram. Finally, 12 hub genes, including PTPRC, TYROBP, FCGR3A, ITGAX, LCP2, IL1B, IRF8, LILRB2, CD68, C1QB, CCR7, and C1QA were identified by using seven different algorithms in Cytohubba. The functional analysis illustrates that these genes were predominantly enriched in immune and inflammation response, lipid and atherosclerosis, and osteoporosis. These results indicate an important role of SLE in inducing excessive inflammation, which may be medicate by these hub genes and can induce osteoporosis and imbalance of the normal mineral balance in the body as well as lipid abnormalities, which eventually leads to premature onset of atherosclerosis. In total, nine transcription factors (TFs) that may participate in regulating the function of these genes were identified. All hub genes and four TFs were validated successfully. Conclusion. The results of our research show that SLE and atherosclerosis have common DEGs, pathophysiology, and hub genes. These findings can provide fresh evidence and insights into a further investigation into the mechanisms at play.http://dx.doi.org/10.1155/2023/4508436
spellingShingle Han Zhang
Yinde Huang
Xin Li
Wenbin Chen
Yu Lun
Jian Zhang
Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis
Mediators of Inflammation
title Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis
title_full Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis
title_fullStr Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis
title_full_unstemmed Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis
title_short Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis
title_sort exploration of hub genes and pathogenetic pathways in systemic lupus erythematosus complicated with early onset atherosclerosis
url http://dx.doi.org/10.1155/2023/4508436
work_keys_str_mv AT hanzhang explorationofhubgenesandpathogeneticpathwaysinsystemiclupuserythematosuscomplicatedwithearlyonsetatherosclerosis
AT yindehuang explorationofhubgenesandpathogeneticpathwaysinsystemiclupuserythematosuscomplicatedwithearlyonsetatherosclerosis
AT xinli explorationofhubgenesandpathogeneticpathwaysinsystemiclupuserythematosuscomplicatedwithearlyonsetatherosclerosis
AT wenbinchen explorationofhubgenesandpathogeneticpathwaysinsystemiclupuserythematosuscomplicatedwithearlyonsetatherosclerosis
AT yulun explorationofhubgenesandpathogeneticpathwaysinsystemiclupuserythematosuscomplicatedwithearlyonsetatherosclerosis
AT jianzhang explorationofhubgenesandpathogeneticpathwaysinsystemiclupuserythematosuscomplicatedwithearlyonsetatherosclerosis